beta

ALNY

Alnylam Pharmaceuticals Inc.

Alny

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.

Market Cap: 13.3 Billion

Primary Exchange: Nasdaq Global Select

Website: http://www.alnylam.com

Shares Outstanding: 99.2 Million

Float: 98.7 Million

Dividend: 0.0 (0.0%)

Beta: 2.669606

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 5.88 Million

Ethical Flags

Animal testing

Longest drawdown: 603 trading days

From: 2015-06-22 To: 2017-11-09

Lowest Point:

Alnylam to Report New Clinical Results for ONPATTRO® (patisiran) at Peripheral Nerve Society (PNS) Annual Meeting and the 5th Congress of the European Academy of Neurology (EAN)

via: Business Wire at 2019-06-13 04:00:00:000

Data from Ongoing Open-Label Extension Study Highlight Durable Halting or Reversal of Neuropathy Disease Progression Relative to Baseline and Consistent Safety Profile of ONPATTRO in Patients with hATTR Amyloidosis Alnylam to Share Data Evaluating Treatment w… read more...

BIIB Is For Buy-O-Gen

via: SeekingAlpha at 2019-06-12 06:30:36:000

Let's spell Biogen Buy-o-Gen. Indeed, BIIB seems increasingly appealing at current price. The biotech focuses on discovering, developing, and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets various products for multiple sc… read more...

Alnylam Pharmaceuticals (ALNY) Investor Presentation - Slideshow

via: SeekingAlpha at 2019-06-10 07:37:51:000

The following slide deck was published by Alnylam Pharmaceuticals, Inc. in conjunction with this Read more … read more...

Alnylam Pharmaceuticals (ALNY) Investor Presentation - Slideshow

via: SeekingAlpha at 2019-06-10 07:37:51:000

The following slide deck was published by Alnylam Pharmaceuticals, Inc. in conjunction with this Read more … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud